$3,500Original price was: $3,500.$2,100Current price is: $2,100.
Retatrutid is a novel peptide drug, a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors. It helps weight loss by regulating appetite, enhancing satiety, and increasing energy expenditure. It also improves cardiovascular-metabolic risk markers like blood pressure, HbA1c, fasting glucose, insulin, cholesterol, and triglycerides, and benefits non-alcoholic fatty liver disease patients by normalizing liver fat. Unlike single or dual agonists, Retatrutid’s triple action offers broader metabolic benefits, making it more effective for weight loss, liver fat reduction, and blood sugar normalization. It’s a promising new choice for obese and type 2 diabetic patients, especially those unresponsive to current treatments.
The peptide will be provided as lyophilized powder to ensure maximum stability.
Semaglutid is a GLP-1 receptor agonist, effective for type 2 diabetes management and weight control. It lowers blood sugar by stimulating insulin secretion and suppressing glucagon release in a glucose-dependent manner. This mechanism helps prevent hypoglycemia, a common side effect of traditional diabetes medications. Semaglutid also aids in weight management by activating the GLP-1 receptors in the brain, leading to increased satiety and reduced food intake. Clinical trials have shown that patients using Semaglutid experienced significant weight reduction. Moreover, Semaglutid has potential cardiovascular benefits, reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes. Its comprehensive benefits, supported by robust clinical evidence, position Semaglutid as a compelling option for individuals seeking effective solutions in diabetes care and weight management.
The peptide will be provided as lyophilized powder to ensure maximum stability.
$3,950Original price was: $3,950.$3,200Current price is: $3,200.
Tesamoreli is a synthetic analog of growth hormone-releasing hormone (GHRH), which is mainly used to treat the abnormal accumulation of abdominal fat in HIV-infected individuals caused by antiretroviral therapy, and it has significant clinical significance and multiple advantages. By mimicking the GHRH produced by the human body itself, it stimulates the anterior pituitary gland to secrete growth hormone, thereby increasing the level of serum insulin-like growth factor I. This, in turn, helps to consume visceral fat and optimize fat distribution. In addition to reducing abdominal fat, it can also optimize body composition, enhance muscle strength, and increase bone density.
$2,600Original price was: $2,600.$2,300Current price is: $2,300.
Tirzepatid is a dual receptor agonist primarily acting on the GIP and GLP-1 signaling pathways. Its effects manifest through synergistic regulation of insulin secretion, inhibition of glucagon release, and enhancement of central satiety signals, thereby improving glucose homeostasis and energy metabolism. Its mechanism integrates endocrine and neural regulation via dual pathways, achieving more comprehensive metabolic control. It holds significant research value in weight management, metabolic syndrome, and related signaling pathway studies.
The peptide will be provided as lyophilized powder to ensure maximum stability.
Join our newsletter and get 10% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
We care about your privacy
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.
